Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

TSX/NOVO stock hub

TSX/NOVO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/NOVOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

277.5B

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/NOVO

In the news

Latest news · TSX/NOVO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.2

P25 11P50 15.6P75 25.4

Trailing P/E10.6

P25 7.4P50 15.6P75 34.3

ROE71.4

P25 -121.5P50 -40.9P75 0.5

ROIC40.4

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/NOVO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

DKK

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	CA
Employees	69,150
Employees Change	-7,844%
Employees Change Percent	-10.14
Enterprise value	CAD 304.4B
Exchange	Toronto Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	CAD 277.5B
Price	CAD 19.1
Price currency	CAD
Rev Per Employee	1,039,586.47x
Sector	Healthcare
Sic	2834
Symbol	tsx/NOVO
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.46%
EV Earnings	11.59x
EV/EBIT	8.74x
EV/EBITDA	8.04x
EV/FCF	23.39x
EV/Sales	4.31x
FCF yield	4.69%
Forward P/E	14.16x
P/B ratio	6.35x
P/E ratio	10.57x
P/S ratio	3.93x
PE Ratio10 Y	25.85x
PE Ratio3 Y	28.73x
PE Ratio5 Y	30.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	49.25%
EBITDA Margin	53.04%
FCF margin	18.43%
Gross margin	83.2%
Gross Profit	CAD 58.7B
Gross Profit Growth	6.28%
Gross Profit Growth Q	27.65%
Gross Profit Growth3 Y	19.81%
Gross Profit Growth5 Y	20.91%
Net Income	CAD 26.3B
Net Income Growth	16.58%
Net Income Growth Q	67.24%
Net Income Growth3 Y	25.89%
Net Income Growth5 Y	23.26%
Pretax Margin	47.49%
Profit Margin	37.2%
Profit Per Employee	CAD 386,775
ROA	19.25
Roa5y	21.35
ROCE	48.33
ROE	71.4
Roe5y	74.56
ROIC	40.42
Roic5y	68.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	16.75
EPS Growth Q	67.08
EPS Growth3 Y	26.65
EPS Growth5 Y	24.4
FCF Growth	-23.77%
FCF Growth Q	12.96%
FCF Growth3 Y	-4.69%
FCF Growth5 Y	4.87%
OCF Growth	-9.84%
OCF Growth Q	-2.61%
OCF Growth10 Y	11.02%
OCF Growth3 Y	11.65%
OCF Growth5 Y	17.37%
Revenue Growth	8.13x
Revenue Growth Q	23.99x
Revenue Growth3 Y	20.3x
Revenue Growth5 Y	20.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.63
Assets	CAD 120.4B
Cash	CAD 4.7B
Current Assets	CAD 38.2B
Current Liabilities	CAD 48.5B
Debt	CAD 31.5B
Debt EBITDA	CAD 0.83
Debt Equity	CAD 0.72
Debt FCF	CAD 2.42
Equity	CAD 43.7B
Interest Coverage	38.38
Liabilities	CAD 76.7B
Long Term Assets	CAD 82.2B
Long Term Liabilities	CAD 28.1B
Net Cash	CAD -26.9B
Net Cash By Market Cap	CAD -9.68
Net Debt EBITDA	CAD 0.72
Net Debt Equity	CAD 0.61
Net Debt FCF	CAD 2.06
Tangible Book Value	CAD 15.8B
Tangible Book Value Per Share	CAD 3.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.79
Inventory Turnover	1.17
Net Working Capital	CAD -9.1B
Quick ratio	0.54
Working Capital	CAD -10.3B
Working Capital Turnover	CAD -1.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.2%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CAD 0.52
Dividend Years	1
Dividend Yield	2.71%
Ex Div Date	2026-03-30
Last Dividend	CAD 0.52
Payout Ratio	42.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	16.44
All Time High	27.58
All Time High Change	-30.75%
All Time High Date	2026-01-16
All Time Low	14.88
All Time Low Change	28.36%
All Time Low Date	2026-03-20
ATR	0.49
Ch YTD	-9.95
High	19.11
High52	27.58
High52 Date	2026-01-16
High52ch	-30.75%
Low	19.06
Low52	14.88
Low52 Date	2026-03-20
Low52ch	28.36%
Ma50ch	16.17%
RSI	72.96
RSI Monthly	0
RSI Weekly	53.67
Sharpe ratio	0.15x
Sortino ratio	0.3
Total Return	2.9%
Tr YTD	-6.82
Tr1m	22.75%
Tr1w	3.3%
Tr3m	-0.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 34.8B
Operating Income Growth	10.7
Operating Income Growth Q	53.69
Operating Income Growth3 Y	25.63
Operating Income Growth5 Y	24.88
Operating margin	49.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,179,265,266%
Net Borrowing	5,208,476,886.3
Shares Insiders	0.02%
Shares Institutions	28.04%
Shares Qo Q	-0.02%
Shares Yo Y	-0.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 12.7B
Average Volume	13,063.05x
Bv Per Share	9.84
CAPEX	CAD -12.5B
Ch1m	22.75
Ch1w	3.3
Ch3m	-3.49
Change	0%
Change From Open	-0.05
Close	19.1
Days Gap	0.05
Depreciation Amortization	2,680,240,765.6
Dollar Volume	1,910
Earnings Date	2026-05-06
EBIT	CAD 34.8B
EBITDA	CAD 37.4B
EPS	CAD 5.9
F Score	4
FCF	CAD 13B
FCF EV Yield	4.27x
Financing CF	-10,865,759,417
Fiscal Year End	December
Founded	1,923
Goodwill	4,285,668,546.1
Graham Number	11.06314
Graham Upside	-42.08
Income Tax	CAD 7.3B
Investing CF	-18,280,290,586
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Lynch Fair Value	CAD 42.04
Lynch Upside	120.1
Ma20	17.4
Ma20ch	9.8%
Net CF	-3,835,391,922
Next Earnings Date	2026-08-05
Open	19.11
P FCF Ratio	21.33
P OCF Ratio	10.88
Payment Date	2026-04-08
Position In Range	80
Ppne	47,428,467,715
Price Date	2026-05-08
Price EBITDA	CAD 7.41
Ptbv Ratio	17.62
Relative Volume	0.01x
Revenue	70,587,921,620x
SBC By Revenue	0.44x
Share Based Comp	309,010,578
Tax By Revenue	10.29x
Tax Rate	21.66%
Volume	100
Z Score	4.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TSX/NOVO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$0.52 annual per share

Payout ratio

+42.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+2.9%

Next ex-dividend date: 2026-03-30

Ownership

Who owns TSX/NOVO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.0%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

TSX/NOVO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.0

Above 70: short-term overbought

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/NOVO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/NOVO stock rating?

tsx/NOVO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/NOVO analysis?

The full report lives at /stocks/tsx/NOVO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/NOVO?

The latest report frames tsx/NOVO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/NOVO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.